Internal Medicine, Endocrinology, Diabetes, & Metabolism · Philadelphia, PA
NPI
1043400567
Since 2007
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
6
Hospital affiliations
3400 Civic Center Blvd., West Pavilion, 4th Floor
Philadelphia, PA, 19104
Phone (215) 662-2300
Groups this clinician bills Medicare through
Medicare paid, 2024
$37K
655 services
Medicare patients, 2024
327
Average age 74
Drug cost, 2024
$3.3M
834 prescriptions
Company payments, 2025
$0
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mona Al Mukaddam was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 248 times for 224 patients. In total Mona Al Mukaddam billed 655 services in 12 codes, and Medicare paid $37K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-11-06.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 248 | 224 | $13.16 | $3,264 |
| 99214 Office E&M - Established | Facility | 182 | 175 | $69.96 | $13K |
| 99215 Office E&M - Established | Facility | 137 | 130 | $101.54 | $14K |
| 99204 Office E&M - New | Facility | 20 | 20 | $91.81 | $1,836 |
| 99205 Office E&M - New | Facility | 17 | 17 | $124.05 | $2,109 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 15 | 15 | $13.29 | $199 |
| 99222 Hospital E&M - Initial | Facility | 13 | 13 | $105.80 | $1,375 |
By year: 2022 $31K for 377 services; 2023 $33K for 427 services; 2024 $37K for 655 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mona Al Mukaddam prescribed most often to Medicare patients was Tymlos (Abaloparatide), with 248 prescriptions and refills. In total Mona Al Mukaddam wrote 834 Medicare prescriptions that cost $3.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tymlos Abaloparatide | 248 | 259 | 43 | $658K |
| Alendronate Sodium Generic | 113 | 286 | 35 | $2,733 |
| Ultra-Fine Mini Pen Needle Pen Needle, Diabetic | 66 | 203 | 35 | $3,602 |
| Forteo Teriparatide | 51 | 51 | Under 11 | $207K |
| Levothyroxine Sodium Generic | 45 | 124 | 14 | $544 |
| Synthroid Levothyroxine Sodium | 34 | 74 | Under 11 | $3,137 |
| Teriparatide Generic | 34 | 34 | 11 | $76K |
| Risedronate Sodium Generic | 27 | 56 | Under 11 | $1,604 |
| Calcitriol Generic | 26 | 63 | Under 11 | $589 |
| Cinacalcet Hcl Generic | 24 | 38 | Under 11 | $8,237 |
| Prolia Denosumab | 17 | 102 | 11 | $29K |
| Actimmune Interferon Gamma-1b,recomb. | 14 | 14 | Under 11 | $902K |
| Crysvita Burosumab-Twza | 11 | 11 | Under 11 | $326K |
Brand drugs: 482 claims; generic drugs: 269 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mona Al Mukaddam $0 (- in general payments such as food, travel and fees) from 3 companies.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.